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Lymphocyte differentiation (Ly)  I antigens serve as useful markers for distinguishing 
thymus-derived (T) lymphocyte subpopulations.  Initially, Boyse and co-workers (1, 2) 
discovered the Ly 1 and Ly 2, 3 alloantigen systems, expressed on partially overlapping 
subsets of T lymphocytes. More recently the number ofknown Ly antigen systems has 
expanded  with  antigens  expressed  on  subpopulations  of T  lymphocytes  (3,  4),  B 
lymphocytes (5-7),  and B and T lymphocytes (8). Boyse and Old proposed early on that 
Ly antigens  are  expressed  differentially on  lymphocyte subpopulations  which  have 
diverged in immunological function (9). RecentlY this proposal has been confirmed by 
Cantor and Boyse (10, 11) who distinguished lymphocytes responsive to major histocom- 
patibility (H-2) complex antigens in mixed lymphocyte culture (MLC) and cell-mediated 
lympholysis (CML) on the basis of Ly 1, 2, and 3 phenotypes. Responder cells in MLC 
were Ly 1  +2-3- T lymphocyte  s whose proliferation was required for the generation of Ly 
1-2+3  + effector cells detectable in CML. However, it is not clear whether the responsive 
lymphocyte subpopulations are specific for the assayed functions, proliferation versus 
cytolysis,  or  specific  for  the  different  target  alloantigens,  I  region-associated  (Ia) 
alloantigens in MLC (12) versus H-2K and H-2D alloantigens in CML (13). 
To understand  more fully the significance of the differential responses of Ly 
1+2-3 - and Ly 1-2+3 + lymphocytes, it is particularly important to elucidate the 
basis for these differential responses. We wished to determine if the subpopula- 
tion of lymphocytes responsive to a class of determinants were dependent on the 
antigenic determinant,  Ia or K/D, rather than on their immunologic function, 
proliferation  or cytolysis. H-2  mutants  provide an  opportunity to  study both 
proliferation  of responders  and  the  generation  of cytotoxic effectors to single 
antigenic determinants  since mutations in H-2K and H-2D region genes have 
generated novel antigenic  specificities detectable in both MLC and CML (14- 
16).  In  this  communication  we  report  observations  made  in  Ly  typing  T 
lymphocytes proliferating  in  response to mutant  H-2K and  H-2D antigens  in 
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primary MLC. Proliferating  T lymphocytes responsive to mutant H-2K  ba and 
H-2K  bf  antigens were classified  as Ly 1+2  + lymphocytes by selective  depletion 
analysis.  The implications of  these results  for our understanding of  T-lympho- 
cyte differentiation  and maturation are discussed. 
Materials and Methods 
Mice.  The mice employed in  this  study and their  respective  genotypes are  presented in  Table 
I.  The mutant H-2  ~a and  H-2  ~I  haplotypes of  the B6.C-H-2  ~ By (B6-H-2  ~a)  and B6.C-H-2  bl  By (B6- 
H-2  #~) mice were discovered by Bailey and Kohn through reciprocal  circle  grafting analyses 
designed to identify  histocompatibility  (H) gene mutations (17).  Complementation tests  demon- 
strafed that both mutations occurred in the K  end of the H-2  ~ haplotype  (18,  19).  Reciprocal, 
primary MLC  of B6-H-2  ~  and B6.H-2  br lymphocytes and B6 lymphocytes result in responder 
proliferation (14,  19).  The H-2  da haplotype of B10.D2 (M504) (B10.D2-H-2  d~) was discovered by 
Egorov and collaborators  to  have diverged from the  H-2  d  haplotype of  B10.D2/n by a mutation in 
the  D region of  H-2  d (20).  B10.D2.H-2  d~  and B10.D2/n lymphocytes are reciprocally  stimulatory in 
primary MLC  (15,  16).  Mice of  the B6.Ly-1  ~ strain  were selected  to be congenic with, but differ 
from, C57BL/6 (B6)  mice at  the  Ly  I locus  (21  ).  B6-Ly 1  ~  mice are  Ly I  a  whereas B6 mice are  Ly 1~. 
Both strains  share the  Ly 2  b, 3  b  genotype. According to genetic convention (22),  Ly I  a and  Ly I  b 
alleles  determine the Ly 1.1 and Ly 1.2 alloantigens,  respectively. 
Antisera.  Anti-Ly and anti-Thy  1 sera were raised by immunization  of recipients with 
thymocytes obtained from congenic donors differing  at the locus  of  interest.  The cell  dosage and 
schedule of immunization and bleeding have been described previously (23).  Anti-Ly 1.1 serum 
was produced by immunization of  (BALB/c × C57BL/10)FI recipients  with B6.Ly 1  ~  thymocytes. 
Anti-Ly 2.2 serum was prepared by immunization of  (C3H.OL x B6-Ly 2~)F~  hosts with C57BL/6 
thymecytes.  Individual sera were tested as suggested by Shen and co-workers (24);  only active 
antisera  were pooled.  Anti-Thy 1.2  serum was produced by  immunization ofA.AKR(Thy  I~,I-I-2  ~) 
mice with A.AL  (Thy  I  b, H-2  ~) thymus  cells. Specificity  tests in complement-dependent 
cytotoxicity  assays demonstrated that this  anti-Thy 1.2 serum is  specific  for  T cells  from Thy I  b 
donors (J. A. Frelinger,  unpublished observations). 
Complement-Dependent Cytotoxicity  Testing.  The alloantigenic  specificity  of all alloantisera 
were tested  in  a complement-dependent cytotoxicity  assay described  by David et  al. (23).  Selected 
young rabbit  serum obtained from Pel-Freeze Farms, Inc.,  (Rogers,  Ark.) served as  the source of 
complement for  tests  with spleen lymphocyte targets. 
Selective  Lymphocyte Depletion.  Lymphocytes bearing selectively  expressed cell-surface  al- 
loantigens were eliminated from lymphocyte populations as  described by Niederhuber et  al. (25). 
Briefly, lymphocytes were suspended in alloantiserum diluted in RPMI-1640  (Microbiological 
Associates Walkersville, Md.  )  + heat-inactivated  fetal  calf  serum (FCS) at a concentration of  5% 
at 10 ×  10  e cells/ml  diluted antiserum.  The antiserum-treated lymphocytes were incubated at 
37°C for 30 rain,  centrifuged, and resuspended in rabbit complement appropriately diluted in 
RPMI-1640 at 10 ×  10  s cells/ml  diluted  complement. After incubation at 37°C for 40 rain,  the 
surviving lymphocytes were resuspended in RPMI-1640 + 5% FCS and washed three times in 
RPMI-1640. 
Mixed Lymphocyte  Culture.  The MLC  was performed as a modification of the procedure 
described by Peck and Bach (26)  as  we have described in a previous communication (27).  Briefly, 
responder cells  were T lymphocytes enriched from Tris-ammonium chloride-treated  spleen cells 
by passage through nylon wool columns (27).  After nylon wool passage, responder T cells  were 
employed in MLC  either  without further treatment or after  selective  lymphocyte depletion with 
antiserum plus complement. Stimulator cells  were Tris-ammonium chloride-treated  spleen cells 
inactivated by mitomycin C  (Sigma Chemical Co., St. Louis, Mo.) treatment. A  total  of one 
million responder and stimulator cells  were mixed in either a 1:1 or 1:3 ratio  in quadruplicate 
cultures  in Click's  medium (29)  without nucleic  acid  precursors but supplemented with Hepes (30 
raM) and normal mouse serum (1%).  The cultures  were incubated for  5 days at  37°C in  humidified 
Lucite  boxes  with an atmosphere of  83% nitrogen, 10% carbon dioxide,  and 7% oxygen. 24  h before 
harvest the  cultures  were pulsed  with [3H]thymidine (New England Nuclear, Boston, Mass. 2 Ci/ 
mM)  at 2 pCi/well. The cultures were harvested and [3H]thymidine  uptake determined as 
described  previously (27).  Specific  [3H]thymidine uptake was calculated  as  a h when the  difference WETTSTEIN,  BAILEY,  MOBRAATEN,  KLEIN,  AND  FRELINGER 
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Strain  H-2  Hap-  Origin of H~-2 regions  Ly l 
lotype  K  I  S  D 
Ly 2 
C57BL/6-Ly I a  b  b  b  b  b  a  b 
C57BL/6-H-2 ~  ba  ba  b  b  b  b  b 
C57BL/6.H.2 b~  bf  bf  b  b  b  b  b 
B10.D2/n  d  d  d  d  d  b  b 
B10.D2(M504) 
(B10.D2-H-2 ~. )  da  d  d  d  da  b  b 
BI0  b  b  b  b  b  b  b 
B10.S  s  s  s  s  s  b  b 
B10.A(1R)  hl  k  k/d  d  b  b  b 
B10.A(2R)  h2  k  k/d  d  b  b  b 
B10.C-H-7 ~  b  b  b  b  b  b  b 
C3H.OL  ol  d  d  k  k  a  a 
C3H.Q  q  q  q  q  q  a  a 
between mean uptake in allogenic and syngeneic cultures differed at the a  =  0.001 level according 
to Student's t test assuming equal variance (30). 
Cell-Mediated  Lympholysis.  The  CML  assay  was  performed  according  to  the  technique 
described by Hirschberg et al.  (31).  All incubations and washes were performed in RPMI-1640 
supplemented with heat-inactivated FCS (10%), gentamycin (0.5%) (Schering Diagnostics, Ken- 
ilworth, N. J.) and 2-mercapteethanol (10  -5 raM). Target cells were lymphoblasts which had been 
generated by incubation of splenic lymphecytes with concanavalin A (2 pg ConA]2 x  106 cells/ml) 
(Calbiochem, San Diego, Calif.) for 2-3 days.  Viable lymphoblasts were separated by flotation on 
Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) followed 
by washes at 50 g.  Lymphoblasts were labeled with ~lCr (Amersham Corp.,  Arlington Heights, 
Ill.), at 200  ~Ci/2  x  108 cells for 60 min, washed four times, and suspended to 2  ×  105 cells/ml. 
Effector cells were generated in MLC under conditions and cell concentrations identical to those 
employed in microculture as described above with the exception that 5 ml of both responder and 
stimulator cells were mixed in 25 cm  2 tissue culture flasks. Effector cells were harvested after 6-7 
days of culture. Effectors were washed twice, counted, and resuspended. 100 ~l of the target and 
effector suspensions were mixed in quadruplicate  in U  bottom wells of microtiter plates  (Flow 
Laboratories, Inc., Rockville, Md.).  The plates were centrifuged for 5 rain at 50 g.  The cultures 
were incubated for 4 h in an atmosphere of 83% N2 10% CO2, and 7% O2 in humidified Lucite boxes 
at 37°C.  After incubation the supernates were collected with the aid of a  Skatron supernatant 
collection system (Flow Laboratories). Total releasable label was the 51Cr released after two cycles 
of freeze-thawing. The specific s~Cr release was determined by the following equation: 
percent specific release  = experimental release  -  spontaneous release 
/total releasable label-spontaneous release x  100. 
Results 
Ly Antisera Characterization.  To insure the correct specificity of the anti- 
Ly  1.1  and  anti-Ly  2.2  sera  employed in  this  study,  specificity tests  were 
performed in complement-dependent cytotoxicity, MLC, and CML. The alloan- 
tigenic specificity of anti-Ly 1.1 and anti-Ly 2.2 sera were tested with B6-Ly 1" 
and B6.Ly 2" splenic lymphocytes in the complement-dependent cytotoxic test. 
The results of this assay are presented in Fig.  1.  Both antisera were strongly 
positive  on  B6-Ly  1"  spleen  cells  and  negative  on  B6-Ly  2"  lymphocytes, 
demonstrating that both sera were specific for their appropriate alloantigens. 1398  T-LYMPHOCYTE  RESPONSE  TO  H.2  MUTANTS 
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FIG.  1.  Complement-dependent  dye exclusion cTLotoxic test of anti-Ly 1.1 and anti-Ly 2.2. 
Left panel sera tested on B6-Ly I a (Ly 1.1 and Ly 2.2) spleen cell targets,  (©  O NMS; 
A  A anti-Ly 1.1; •  •  anti-Ly 2.2).  Right panel, sera tested on B6-Ly 2 a (Ly 1.2 and 
Ly 2.1).  Same symbols as left. 
TABLE  II 
Specificity of Anti-Ly Sera for Selective Depletion of Responder T  Cells in MLC 
Respond-  Ly I, 2 Pheno-  Stimulator  Antiserum + C  Inhibi- 
ers  type  tion* 
h cpm*  % 
B6-Lyl ~  Ly 1.1,  2.2  B10.D2  NMS (1/40)  72,180  43 
a-Ly 1.1  (1/40)  45,768 
B10.S  Ly 1.2,  2/2  B10.D2  NMS (1/40)  114,011 
a-Ly 1.1  (1-40)  102,512  10 
C3H.Q  Ly 1.1,  2.1  C3H.OL  NMS (1/20)  211,298 
a-Ly 1.1  (1/20)  25,470  88 
B10.S  Ly 1.2,  2.2  B10.D2  NMS (1/20)  140,503 
a-Ly 2.2  (1/20)  164,248  -17 
B10  Ly 1.2,  2.2  B10.A (2R)  NMS (1/10)  129,383 
a-Ly 2.2  (1/10)  112,055  13 
* h =  Mean [SH]thymidine uptake for allogeneic combination - mean [3H]thymidine uptake for 
syngeneic combination. Computed when the two means differ  at a -< 0.001. 
* Inhibition = (A after  alloantiserum + C treatment/A after  normal mouse serum + C treatment) 
x 100. 
The slight degree of nonspecific lysis observed in the complement-dependent 
cytotoxic test does not necessarily indicate that a similar lack of specificity will 
be observed in depletion ofT-lymphocyte  function, due to the greater sensitivity 
of the analytical dye exclusion cytotoxic test. Both the alloantigenic and T-cell 
subpopulation specificity of the Ly antisera were tested by pretreatment of MLC 
responder T  cells  and  CML  effector T  cells with  antisera plus complement. 
Responder  and  stimulator  cells  mixed  in  MLC  were  incompatible  at  the I 
region, K  region, and/or D  region. Nylon wool T cells obtained from Ly I a and 
Ly  1 #  donors  were treated with  anti-Ly  1.1  serum or  normal  mouse serum 
(NMS) + complement (C). The results are presented in Table II. Relative to the 
effects of NMS  +  C, anti-Ly 1.1  +  C depleted the proliferative response of Ly 
1.1-positive  responder  cells  (B6-Ly  I a  and  C3H.OL)  with  no  effect  on  the WETTSTEIN,  BAILEY,  MOBEAATEN,  KLEIN,  AND  FRELINGER 
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Effector cell donor  Ly 1, 2 Phone-  Target  Antiserum + C  % ~lCr Release*  Inhibi- 
type  tion* 
% 
(B10.C-H-7 ~ × C3H.OL)F,  Ly 1.1/1.2  C3H.Q 
Ly 2.1/2.2 
B10.C-H-7 # 
-  60.8 ± 3.8 
NMS (1/20)  50.2 ± 4.2 
a-Ly 1.1 (1/20)  41.2 ± 1.9 
a-Ly 2.2 (1/20)  0§ 
-  0 
NMS (1/20)  0 
¢~-Ly 1.1 (1/20)  0 
a-Ly 2.2 (1/20)  0 
17.6 
100.0 
* Effector: target ratio of 20:1. 
* Inhibition =  (SlCr  release  after  antiserum  + C/61Cr  release after NMS + C) x  100. 
§ ~r  release reported as zero when value is less than or equal to zero. 
TABLE  IV 
Ly 2 Typing oft Cells Proliferating in MLC to H-2D Alloantigen Determined by the H- 
2Dd: H-2D da AUelic Combination 
Target 
Responder  Ly 2  Phe-  Stimulator  anti-  Antiserum  Inhibi- 
notype  +  C  tion* 
gens 
B10.D2  Ly 2.2  B10.D2-H-2 da  H-2D da 
B10.D2-H-2 da  Ly 2.2  B10.D2  H-2D d 
A cpm*  % 
--  151,222 
NMS  152,462  -  1 
a-Thy  1.2  0  100 
a-Ly  2.2  12,337  92 
-  24,284 
NMS  10,772  56 
a-Thy  1.2  0  100 
a-Ly  2.2  2,548  90 
* As in Table If. 
As in Table II. 
response of Ly 1.1-negative responders (B10.S).  Therefore, the anti-Ly 1.1 serum 
was specific for the Ly 1.1 alloantigen on T cells proliferating in primary MLC. 
The T-cell subpopulation  specificity of anti-Ly 2.2  serum was determined by 
treating nylon wool T cells obtained from Ly 2 b donors with anti-Ly 2.2 serum 
+  C before culture with H-2-incompatible stimulators. The results of this assay 
are included in Table II. Anti-Ly 2.2  +  C  did not deplete B10.S and B10 T cells 
responsive in MLC to B10.D2 and B10.A(2R) stimulators.  Anti-Ly 2.2 but not 
anti-Ly 1.1 serum plus complement depleted (C3H.OL × B10.C-H-7b)F1 effectors 
specific for C3H.Q targets  (Table III). These observations are consistent with 
previous reports in demonstrating that T lymphocytes proliferating in response 
to H-2-incompatible stimulators in MLC are Ly 1+2  - whereas the cytotoxic effec- 
tors specific for H-2-alloantigens are Ly 1-2  + (10, 11). 
Ly  Typing of H-2  Mutant Antigen-Responsive  T  Lymphocytes.  We  Ly 2 
typed the T  cells proliferating in  reciprocal primary MLCs  of B10.D2/n  and 
B10.D2-H-2 da  lymphocytes.  The  results  of this  experiment are presented  in 
Table IV. Relative to the inhibition observed with NMS  +  C, anti-Ly 2.2  +  C 1400  T-LYMPHOCYTE  RESPONSE  TO  H-2  MUTANTS 
TABLE  V 
Ly Typing ofT Cells Proliferating in MLC to H-2K ~  and H-2KbI Mutant Alloantigens 
Inhibi-  Ly 1, 2  Target an-  Antiserum +  C  Responder  Phenotype  Stimulator  tigen  tion* 
A cpm*  % 
B6-Ly 1  a  Ly 1.1,  2.2  B6-H-2  b~  H-2K ba  -  49,422 
NMS  51,268 
a-Thy 1.2  0  100 
a-Ly 1.1  0  100 
a-Ly 2.2  1,597  97 
a-Ly 1.1  699  99 
a-Ly  1.1  treated 
cells mixed with 
a-Ly 2.2-treated 
cells 
B6-H-2 bs  H.2Kb* 
B10.A(1R)  H-2KkI  kid 
-  13,325 
NMS  5,866 
~-Thy 1.2  0 
~-Ly 1.1  0 
~-Ly 2.2  0 
~-Ly 1.1-  0 
a-Ly  1.1  treated 
cells mixed with 
a-Ly 2.2-treated 
cells 
-  NT 
NMS  124,857 
a-Thy 1.2  2,065 
a-Ly 1.1  2,843 
a-Ly 2.2  97,335 
a-Ly  1.1-treated  50,030 
cells mixed with 
a-Ly 2.2-treated 
cells 
100 
100 
100 
100 
98 
98 
22.1 
60 
* As in Table II. 
$ As in Table II. 
and anti-Thy 1.2 + C eliminated the T cells responsive in reciprocal MLCs. This 
observation strongly indicated that T  lymphocytes proliferating in response to 
the antigens  defined by the H-2Dd: H-2D  da responder:  stimulator combination 
are Ly 2 +. Although we did not have the anti-Ly 1.2 sera available to Ly 1 type 
these responders it is clear that these proliferating T cells expressed a different 
phenotype than Ly 1+2 - responders in/-region disparate MLC. 
A  more definitive Ly typing of H-2K mutant antigen-responsive T  cells was 
accomplished through the use of anti-Ly 1.1 and anti-Ly 2.2 sera and B6-Ly 1 ~ T 
cells. B6-Ly la T cells were pretreated with anti-Ly 1.1 or anti-Ly 2.1  +  C and 
mixd in primary MLC with mitomycin C-treated spleen cells from B6-H-2 b~, B6- 
H-2 b~, and B10.A(1R) mice. The results are presented in Table V. B6-Ly 1 ~ mice 
are  congenic  with  the  Boyse  substrain  of  B6,  differing  at  a  segment  of 
chromosome encompassing the Ly 1  locus.  The long separation of the B6/Boy WETTSTEIN,  BAILEY,  MOBRAATEN,  KLEIN,  AND  FRELINGER  1401 
and  B6/By  (background  strain  of  B6-H-2 ba  and  B6-H-2 b1  congenic  strains) 
suggests that there is a high probability that the two substrains differ by one or 
more H  loci. However, .primary cultures of B6-Ly 1.a responder cells and B6/By 
stimulator cells do not result in detectable proliferation.  We are confident that 
the observed proliferation of B6.Ly 1 ~ responders mixed with B6-H-2 b~ and B6- 
H-2 ~s stimulators is specific for H-2K  ba and H-2K  ~s alloantigens.  Responders to 
both mutant stimulators and B10.A(2R) stimulators were depleted by anti-Thy 
1.2  and  anti-Ly  1.1  serum plus  C.  The  crucial  experiment  was pretreatment 
with anti°Ly 2.2 +  C. This treatment resulted in depletion of the T-cell response 
to both B6-H-2 ba  and  B6-H-2 bf stimulators.  The  same treated cells responded 
normally to B10.A(1R) stimulators.  These results intimated that  proliferation 
in MLC to H-2K-incompatible stimulators in contrast to I  region-incompatible 
stimulators was mediated by Ly 1+2 + T cells or required cooperation of Ly 1+2 - 
and Ly 1-2 + T cells. To discriminate between these two alternatives,  we tested 
the ability of mixtures ofT cells depleted of Ly 1  + cells and T cells depleted of Ly 
2 + cells to respond to mutant stimulators.  These results are included in Table 
V. Mixtures of Ly 1- and Ly 2- T cells were unresponsive to both H-2K b mutant 
stimulators indicating that the lymphocytes responding to H-2K  b~ and H-2K  °s 
antigens were Ly 1+2 +. 
Discussion 
Lymphocyte differentiation antigens have long been believed to be expressed 
differentially on lymphocyte subpopulations which have diverged functionally 
during development and maturation.  This supposition has been confirmed by 
the demonstration that T cells proliferating in primary MLC in response to H- 
2K plus I  region gene ceded alloantigens are Ly 1+2-3 -  (10) whereas H-2K  and 
H-2D-specific  cytotoxic T  cells  (11) and  specific suppressor T  cells  (32) are Ly 
1-2+3 +. As a first step in elucidating the basis for the differential response of Ly 
1+2-3 - and Ly 1-2+3 + cells to H-2 associated antigens, we have Ly-typed T cells 
responding in MLC to mutant H-2K and H-2D antigens, detectable in both MLC 
and CML. The results reported in this communication demonstrate that the B6- 
Ly la T  lymphocytes proliferating in response to B6-H-2 ba and B6-H-2 of stimu- 
lators are Ly 1+2 +. These observations are in contrast to those indicating that 
the B6-Ly 1 ~ responders to H-2K- and I-incompatible B10.A(1R) stimulators are 
Ly 1+2 -.  Based on numerous prior observations by others (12,  13) we presume 
that the proliferative response by B6oLy 1 ~ T cells to B10.A(1R) stimulators was 
primarily  specific for foreign I region determinants.  Therefore,  we have dem- 
onstrated that responder T  cells specific for I-incompatible stimulators are Ly 
1+2-3 -, whereas T cells required for proliferation in MLC to H-2K-incompatible 
stimulators are Ly 1+2 +. While we have not yet established with certainty that 
the proliferating  cells themselves are Ly 1+2 +,  preliminary  data from experi- 
ments involving antiserum  +C treatment 5 days after in vitro stimulation, but 
before [3H]thymidine addition support the contention that the proliferating cells 
are Ly 1+2 +. The obvious conclusion from these observations is that at least some 
of the T  lymphocytes proliferating in response to foreign alloantigeneic deter- 
minants  in primary MLC need not be limited to the Ly 1+2 -  subpopulation.  It 
would appear  that  the  subpopulation  of responsive  T  cells  is determined  by 1402  T-LYMPHOCYTE  RESPONSE  TO  H-2  MUTANTS 
either  the  identity  of the  foreign  alloantigenic  determinants  or the  molecule 
carrying those determinants.  To resolve this question we have initiated studies 
to Ly type T cells proliferating in MLC to alloantigens defined by combinations 
of respenders and stimulators differing at only the H-2K or H-2D  regions. 
This  is  not the  only system  in  which  Ly  1+2 + cells have  been  implicated. 
Shiku et al. reported that cytotoxic effector cells for syngeneic tumors were Ly 
1+2 + (33). These results have been recently expanded by Stutman et al.  (34) who 
showed that the effectors were actually Ly 1-2 +, but that an Ly 1+2 + amplifier 
was required for efficient expression of that cytotoxicity. Similarly Cantor and 
Boyse reported that an Ly 1+2 + population was required for the generation  of 
killer  cells  specific  for  TNP  modified  syngeneic  cells  but  that  the  killers 
themselves were Ly 1-2 + (35).  Earlier  Pang et  al.  showed that  depletion by 
either anti-Ly 1  ÷ or anti-Ly 2 + would inhibit a secondary, virus-specific cytotoxic 
response  but  they  did  not  perform  the  critical  reconstitution  experiment 
necessary to determine if an Ly 1+2 + cell was required  (36).  In contrast to the 
data here for H-2 mutant  products Pang et al.  could demonstrate  no effect of 
anti-Ly  2  on  the  secondary  virus  induced  proliferative  response.  We  should 
point out that  the mutant  stimulated  MLC is the incorporation  equivalent to 
that seen in most I region differences. Thus this makes the observation reported 
here that a Ly 1+2 + is required for proliferation stimulated K or D mutants even 
more striking. 
The  observations  reported  in  this  communication  are  important  for  the 
understanding of the development and maturation  of T lymphocytes. Previous 
hypotheses of T  cell differentiation  have proposed that  Ly 1+2 + cells serve as 
progenitors for more mature  Ly 1"2- and Ly 1-2 + T  cells  (10).  Our results in 
MLC reject this  simple progression  as an  all  inclusive explanation  for T  cell 
differentiation.  T  cells  capable  of  responding  immunologically  to  in  vitro 
stimulation  in MLC must exist within the Ly 1+2 + subpepulation of a  normal 
animal. Before a clear impression of T lymphocyte development and maturation 
can  be obtained,  a  more  extensive  characterization  of the  Ly-differentiation 
antigen phenotype of virgin and mature T cells is required. 
Summary 
We have determined the Ly phenotype of the T lymphocytes which proliferate 
in response to mutant H-2K and H-2D alloantigens in primary mixed lympho- 
cyte culture. Responder T cells proliferating in reciprocal cultures of H-2d(KdD d) 
and H-2da(KdDda)  lymphocytes were typed Ly 2 + through  selective depletion 
with specific alloantiserum  plus complement.  Further,  B6-Ly 1  a lymphocytes 
proliferating in response to B6-H-2 ba and B6-H-2 b~ stimulators were typed as Ly 
1+2 + through similar analysis.  These results are discussed with regard to their 
impact  on  views  of lymphocyte  differentiation  and  factors  determining  the 
identity of alloreactive lymphocytes. 
We thank Glen Matsushima for his help in antiserum production. 
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